Mast cell and serum levels of GRO-α, ENA-78, and VEGF were significantly higher in MM patients compared to controls, and significant correlations were found between mast cell density with VEGF, GRO-α, ENA-78, and with a Ki-67 plasma cell proliferative index. This evidence concerns the gene CXCL1 and Miyoshi myopathy.